Aviado Bio raised $80 million series A led by New Enterprise Associates (NEA) and co-led by Monograph Capital

Biotech Health services Manufacturing Pharma

Investments

13 December 2021

Aviado Bio (company)

Biotech Health services Manufacturing Pharma

Total investments received (USD): 115.69m

Round value (USD): 80m

Round investors: Advent Life Sciences F-Prime Capital LSP (Life Sciences Partners) New Enterprise Associates JJDC - Johnson & Johnson Dementia Discovery Fund LifeArc Ventures Monograph Capital

Industry: Biotech Health services Manufacturing Pharma

AI (big data) Biotech Health services Software Services

Investments 05 June 2022

Health services Manufacturing Pharma

Investments 26 April 2022

Biotech Health services

Investments 09 March 2022

Biotech Health services Manufacturing

Investments 03 March 2022

Biotech Health services Manufacturing

Investments 09 January 2022